Introduction: More than 100 million populations globally suffer from Osteoarthritis (OA) which is considered the leading cause of disability. The prevalence of OA knee in India is about 6% of total osteoarthritis. Therefore, there is a need for alternative and well-tolerable supplementary treatment which has no drug interaction with conventional drugs for OA. Aim and objectives: To evaluate the effect of traditional sudation therapy (Nadi Swedana) on pain, swelling and stiffness of patients with knee osteoarthritis. Method: The study was conducted after getting approval from Institutional Ethical Committee and was registered to the Clinical Trials Registry of India (CTRI/2018/03/012636 19/03/2018). A total of 20 patients with knee joint osteoarthritis were treated for 6 weeks. Pre-test and the post-test outcome measure was recorded on subjective parameters and statistically analyzed. Results: The applied score for pain, swelling and stiffness decreased significantly lower after the intervention (p<0.05). Conclusions: Traditional sudation therapy by Nadi Swedana was beneficial for patients with knee osteoarthritis.

The World Health Organization TB (Tuberculosis) statistics for India for 2018 give an estimated incidence of 2.69 million cases.TB is being a challenge for India and worldwide developing countries pre and post antitubercular drug era. The major limitations clinicians face in management of TB is its MDR, immunosuppression, bad prognosis during course of treatment and associated side effects of anti- tubercular drugs putting patient in danger for multiple organ failure. The presence of comorbidities, nutritional deficiencies add up toll in the whole clinical presentation of tuberculosis management. There is very systematic pathophysiology and treatment ideology explained in Ayurveda for tuberculosis and related respiratory infections. There is great need to integrate Ayurveda wisdom of understanding tuberculosis and medicinal herbs in protective mode with aggressive targeted anti TB activity of modern medicine. Ashwagandha is strong Rasayana category medicinal plants with ancient references for its beneficial effect in management of tuberculosis also supported by modern day in vitro, in vivo and clinical evidences of effectiveness of Ashwagandha in management of tuberculosis could be ray of hope. There should focused research aimed at unfolding mechanisms and clinical guidelines for the use of Ashwagandha as an adjuvant in themanagement of tuberculosis.